Literature DB >> 10588509

Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis.

M Bergmann1, A Gornikiewicz, T Sautner, E Waldmann, T Weber, M Mittlböck, E Roth, R Függer.   

Abstract

Studies performed on healthy volunteers have revealed that catecholamines down-regulate the lipopolysaccharide (LPS)-induced production of tumor necrosis factor (TNF)alpha, interleukin (IL)-6, and IL-1beta. We extended this observation and show that this effect is based on changes in the mRNA concentration of these cytokines. Catecholamines are increased in severe sepsis due to endogenous production and have to be administered exogenously when the disease has proceeded to the state of prolonged hypotension. We here investigated whether the immunomodulating effect of catecholamines could also be demonstrated in the blood of patients with prolonged severe sepsis and of those in prolonged septic shock. Blood was stimulated ex vivo with LPS in the presence and absence of epinephrine and the cytokine protein concentration was determined. In blood of healthy volunteers, epinephrine reduced the LPS-stimulated synthesis of TNFalpha by 62.5% (P< 0.0001), of IL-6 by 39% (P< 0.0001), and of IL-1beta by 40% (P= 0.015), and increased the LPS-stimulated IL-10 production by 77.8% (P < 0.0001). Correspondingly, in blood of patients with prolonged severe sepsis, TNFalpha was reduced by 67.2% (P < 0.0001) and IL-6 was reduced by 32.9% (P < 0.0001); IL-1beta and IL-10 were not modulated by catecholamines in these patients. In blood samples of patients in prolonged septic shock, epinephrine did not modulate cytokine levels of IL-6 and IL-10, and decreased TNFalpha only by 36.4% (P < 0.0001). Interestingly, epinephrine suppressed the IL-1beta production by 73% (P < 0.0001) in blood of patients in prolonged septic shock, which was twice as much as in blood samples of healthy volunteers. The altered response of septic blood to catecholamines might be due to an altered reactivity of leukocytes in the prolonged disease although an additional role of preexisting catecholamines cannot be completely excluded.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588509     DOI: 10.1097/00024382-199912000-00002

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  29 in total

1.  Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans.

Authors:  R L Starkie; D J Angus; J Rolland; M Hargreaves; M A Febbraio
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

Review 2.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease.

Authors:  Michael Gleeson; Nicolette C Bishop; David J Stensel; Martin R Lindley; Sarabjit S Mastana; Myra A Nimmo
Journal:  Nat Rev Immunol       Date:  2011-08-05       Impact factor: 53.106

Review 4.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Comparison of serum and cell-specific cytokines in humans.

Authors:  J Jason; L K Archibald; O C Nwanyanwu; M G Byrd; P N Kazembe; H Dobbie; W R Jarvis
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 6.  β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.

Authors:  Tyler J Loftus; Philip A Efron; Lyle L Moldawer; Alicia M Mohr
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

Review 7.  Neural pathways involved in infection-induced inflammation: recent insights and clinical implications.

Authors:  Marion Griton; Jan Pieter Konsman
Journal:  Clin Auton Res       Date:  2018-03-14       Impact factor: 4.435

Review 8.  Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box?

Authors:  Michael A Flierl; Daniel Rittirsch; Markus Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

9.  Adrenergic Effect on Cytokine Release After Ex Vivo Healthy Volunteers' Whole Blood LPS Stimulation.

Authors:  Vasiliki Papandreou; Nadia Kavrochorianou; Theodoros Katsoulas; Pavlos Myrianthefs; Kyriaki Venetsanou; George Baltopoulos
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 10.  Bench-to-bedside review: Beta-adrenergic modulation in sepsis.

Authors:  Etienne de Montmollin; Jerome Aboab; Arnaud Mansart; Djillali Annane
Journal:  Crit Care       Date:  2009-10-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.